Merck’s Oxytrol Could Be OTC Trailblazer For Chronic Conditions
This article was originally published in The Tan Sheet
Executive Summary
Merck’s Oxytrol for Women has the opportunity to “create the market” for OTC overactive bladder drugs, as well as encourage other switches for chronic, progressive conditions, marketing consultant Joe McGovern says. The transdermal patch product is slated to launch in September.